Targeting the serotonin 2C receptor for the treatment of obesity and type 2 diabetes.
Marston
Oliver J
OJ
Department of Pharmacology, University of Cambridge, Cambridge, UK. gtswanson@northwestern.edu
Heisler
Lora K
LK
D000818:Animals; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D016503:Drug Delivery Systems; D006801:Humans; D009765:Obesity / Q000188:drug therapy*; D044405:Receptor, Serotonin, 5-HT2C / Q000502:physiology; D058826:Serotonin 5-HT2 Receptor Agonists
D044405:Receptor, Serotonin, 5-HT2C; D058826:Serotonin 5-HT2 Receptor Agonists